MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000533666

Медицинская библиотека · Acta haematologica · 2023

Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia.

Saussele Susanne, La Rosée Paul, Kiani Alexander, Haverkamp Wilhelm, Jentsch-Ullrich Kathleen, Stegelmann Frank, Rieger Christina, Waller Cornelius F, Franke Georg-Nikolaus, Junghanss Christian, Kirchmair Rudolf, Theurl Markus, le Coutre Philipp

СтатьяОбзорConsensus StatementПеревод пока не подготовлен

Аннотация

BACKGROUND

Based on the new data from the primary analysis of the OPTIC (Optimizing Ponatinib Treatment in CP-CML) trial on dose optimization of ponatinib in patients with chronic phase (CP)-CML, the German consensus paper on ponatinib published in 2020 (Saussele S et al., Acta Haematol. 2020) has been updated in this addendum.

SUMMARY: Focus is on the update of efficacy and safety of ponatinib, reflecting the new data set, as well as the update of the benefit-risk assessment and recommendations for ponatinib starting dose in CP-CML - provided that the decision to use ponatinib has already been made. Furthermore, based on OPTIC and additional empirical data, the expert panel collaborated to develop a decision tree for ponatinib dosing, specifically for intolerant and resistant patients. The recommendations on cardiovascular management have also been updated based on the most recent 2021 guidelines of the European Society of Cardiology (ESC) on cardiovascular disease prevention in clinical practice.

KEY MESSAGES: The OPTIC data confirm the high efficacy of ponatinib in patients with CP-CML and provide the basis for individualized dose adjustment during the course of treatment.

Для цитирования: Saussele Susanne, La Rosée Paul, Kiani Alexander, Haverkamp Wilhelm, Jentsch-Ullrich Kathleen, Stegelmann Frank, Rieger Christina, Waller Cornelius F, Franke Georg-Nikolaus, Junghanss Christian, Kirchmair Rudolf, Theurl Markus, le Coutre Philipp. Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia.. Acta haematologica. 2023. DOI: 10.1159/000533666.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.